Our data approach has been accepted by the majority of the largest pharmaceutical companies, as it reduces regulatory and compliance risk, is customizable, increases HCP acceptance of compensation fairness, and can be delivered in almost any format to meet existing FMV system needs. Our FMV customers currently include over 100 companies, and we are the provider of choice to the world’s largest pharmaceutical companies.
We pride ourselves on exceptional, personalized customer service, an assertion supported by the endorsements from our clients. We are the FMV data provider of choice for the pharmaceutical industry.
Overview
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 15, 2012 | 5 things that have influenced pharmaceutical digital marketing expansion | The recession: The need to scale back advertising spend was the obligatory pebble in the water that prompted pharmaceutical companies to take a hard look at their TV and print advertising spend and turn their heads to the relatively lower c... |
| Sep 14, 2011 | GSK’s new drug marketing model: Pharma reps as educators, not sellers | The new system also evaluates a rep’s scientific knowledge as well as the ability to communicate that information. Millar, who helped design the new GSK program, said GSK’s goal isn’t necessarily to sell as much medicine as possible. The go... |
| Pharma patient adherence budgets have increased 281 percent in four years | Patient adherence is a hot topic for the healthcare industry because it can impede or undermine patients’ recovery or a chronic condition. Non adherence costs an estimated $290 billion in hospitalization stemming from complications. For the... | |
| 5 things that have influenced pharmaceutical digital marketing expansion | Pharmaceutical companies have been increasing their investment in digital marketing strategies including websites, e-marketing and social media, despite the potential risks that lurk just below the surface like so many stinging jellyfish th... | |
| GSK’s new drug marketing model: Pharma reps as educators, not sellers | A GlaxoSmithKline (NYSE:GSK) pharmaceutical sales representative these days still works to get in front of a physician’s desk to discuss GSK drugs. But their conversation today is vastly different compared to one a year ago. That’s by desig... |
Reviews 0
FAQ about Cutting Edge Information
When was Cutting Edge Information founded?
Cutting Edge Information was founded in 2002.
What has the press written about Cutting Edge Information?
Parsers VC has collected 6 articles mentioning Cutting Edge Information, among them “5 things that have influenced pharmaceutical digital marketing expansion” (Aug 15, 2012) and “GSK’s new drug marketing model: Pharma reps as educators, not sellers” (Sep 14, 2011).
Is Cutting Edge Information still active?
Yes, Cutting Edge Information is active; its latest activity on Parsers VC dates from Oct 12, 2012.